Founded in 2015, Wellthy Therapeutics operates in Enterprise Tech industry. Initially focusing on diabetes management, the company has expanded its platform to address other chronic illnesses by integ...
Funding stage:
Venture Round
Last funding:
15/12/2020
Total funding:
$7.61 Mn+
Revenue:
Investors
Employee count:
56
Last 90d
56
Last 90d
Web traffic:
7.64K
7.64K
Last 30d
Last 30d
Wellthy Therapeutics: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders26
Latest Filing Date28 Dec 2024- Funding Events20
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Wellthy Therapeutics
As of 29 December 2024, Wellthy Therapeutics's equity is held by 25 shareholders, with the top three being Abhishek Shah, Saama Capital IV Ltd, and TruDoc.
Abhishek Shah holds the largest stake in Wellthy Therapeutics at 28.1% as of 29 December 2024.
As of 29 December 2024, founders collectively hold 28.9% equity in Wellthy Therapeutics.
As of 29 December 2024, investors collectively hold 39.0% equity in Wellthy Therapeutics.
Wellthy Therapeutics's ESOP pool stands at 8.4% of total equity as of 29 December 2024.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links